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Hyaluronan is a component of the extracellularmatrix, which
affects tissue homeostasis. In this study, we investigated the reg-
ulatory mechanisms of one of the hyaluronan-synthesizing
enzymes, HAS2. Ectopic expression of Flag- and 6myc-HAS2 in
COS-1 cells followed by immunoprecipitation and immuno-
blotting revealed homodimers; after co-transfection with Flag-
HAS3, alsoheterodimerswere seen. Furthermore, the expressed
HAS2 was ubiquitinated. We identified one acceptor site for
ubiquitin on lysine residue 190. Mutation of this residue led to
inactivation of the enzymatic activity of HAS2. Interestingly,
K190R-mutated HAS2 formed dimers with wt HAS2 and
quenched the activity of wt HAS2, thus demonstrating a func-
tional role of the dimeric configuration.
Hyaluronan is abundantly found in tissues throughout the
body and has key roles in tissue organization and homeostasis
(1). Abnormal accumulation of hyaluronan in tissues and
serum is associated with the progression of many diseases,
such as inflammatory diseases and cancer (2–5). The biosyn-
thesis of hyaluronan is tightly regulated by growth factors
and cytokines as well as other stimuli that promote wound
healing, inflammation, or transformation. External regula-
tory signals, such as platelet-derived growth factor (PDGF)-
BB, transforming growth factor (TGF)-, and phorbol
12-myristate 13-acetate (PMA), regulate both the size (6)
and amount of the produced hyaluronan (7–14).
The hyaluronan-synthesizing enzymes (HAS)4 were cloned
and characterized first in the bacterium Streptococcus pyogenes,
and then in mammals, where three different HAS isoforms
were characterized, HAS1, HAS2, and HAS3 (15, 16). Studies
by us and other laboratories (6, 11) revealed that growth factor-
mediated increase of hyaluronan synthesis is often due to
induction of the HAS2 gene in fibroblasts, whereas external
signals have been shown to predominantly regulate HAS1 and
HAS3 transcripts in synoviocytes and keratinocytes, respec-
tively (12, 14, 17). In addition to the regulation of HASs at the
transcriptional level (6, 11, 13, 14), there is evidence that the
activity of HAS isoforms is regulated by phosphorylation by
protein kinase C (PKC), protein kinase A (PKA), calcium-de-
pendent protein kinase, and extracellular signal-regulated
kinase (10, 18–20). Prediction from their amino acid sequences
suggests thatHASs aremulti-passmembrane proteins (15) that
occur in the plasmamembrane, but there are also evidence that
much of the HAS enzymes reside at intracellular localizations
including perinuclearmembrane, endoplasmic reticulum (ER)-
Golgi pathway, and endocytic vesicles (21–23).
Ubiquitination of proteins affects their stability, activity,
interaction with other proteins as well as subcellular localiza-
tion and trafficking (24, 25). Modification of a protein with
K48-linked poly-Ub chains can trigger the proteasomal degra-
dation of the protein. The functional consequences of protein
ubiquitination byK63-linked poly-Ub chains include activation
of proteins or alteration of their trafficking. Protein modifica-
tion bymonoubiquitination, at one or several positions, is asso-
ciated with protein sorting at the plasma membrane and endo-
somes, targeting them to the interior of multivesicular bodies,
which leads to their transport to lysosomes (24, 26, 27).
Because regulatory ubiquitination modulates the function of
cellular proteins similar to that of phosphorylation, we investi-
gated in the present study whether HAS2 is subjected to regu-
latory ubiquitination, and its consequences for the activity and
stability of HAS2. Furthermore, we demonstrate that HAS2
forms homo- and/or hetero-oligomers.
MATERIALS ANDMETHODS
Antibodies—The following primary antibodies were used:
rabbit antisera against HAS2 (CGR; (28)) and against HAS3
(Abcam); mouse monoclonal antibodies against FlagM2 (IgG1,
Sigma-Aldrich), c-Myc (9E10 IgG1, Santa Cruz Biotechnology),
influenza hemagglutinin A (HA) antiserum (anti-HA, Y-11;
Santa Cruz Biotechnology) and to ubiquitin (P4D1 clone IgG1,
Santa Cruz Biotechnology); goat anti-mouse and goat anti-rab-
bit horseradish peroxidase IgG (GE Healthcare).
Construction of Transcripts, Cell Culture, and Transfection—
The cDNAs encoding the open reading frames of mouseHAS2
and HAS3 genes in pcNeoI plasmid (29, 30), kindly provided
byDr. A. Spicer, were excised byXhoI/XbaI digestions followed
by ligation in Flag-, 6myc-, or HA-pcDNA3 vectors, fused in-
* Thisworkwas supported in part by grants from the SwedishCancer Society,
Wenner-Gren Foundation, and Mizoutani Foundation for Glycoscience.
□S The on-line version of this article (available at http://www.jbc.org) contains
supplemental Figs. S1 and S2.
1 These authors contributed equally to this work.
2 Recipient of FEBS Fellowships.
3 To whom correspondence should be addressed: Ludwig Institute for
Cancer Research, Uppsala University Biomedical Center, Box 595,
SE-75124 Uppsala, Sweden. Tel.: 0046-18-160414; Fax: 0046-18-160420;
E-mail: Evi.Heldin@LICR.uu.se.
4 The abbreviations used are: HAS, hyaluronan synthase; wt, wild type; Ub,
ubiquitin; MALDI-TOF, matrix-assisted laser desorption/ionization-time of
flight; HA, hemagglutinin.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 285, NO. 31, pp. 23647–23654, July 30, 2010
© 2010 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in the U.S.A.
JULY 30, 2010•VOLUME 285•NUMBER 31 JOURNAL OF BIOLOGICAL CHEMISTRY 23647
 at UNIV. O
F INSUBRIA, on O
ctober 22, 2010
w
w
w
.jbc.org
D
ow
nloaded from
 
http://www.jbc.org/content/suppl/2010/05/26/M110.127050.DC1.html
Supplemental Material can be found at:
frame at their N termini. Plasmids were purified (PlasmidMaxi
kit, Qiagen) and sequenced to confirm that the insertions were
in-frame. HA-ubiquitin wild-type (HA-Ub wt) and HA-Ub
chains mutated at Lys-48 or Lys-63, HA-Ub K48R, and HA-Ub
K63R, respectively, cloned in pcDNA3 vectors, were gifts from
Drs I. Dikic andK.Haglund (GoetheUniversity, Frankfurt, Ger-
many; Ref. 31).
SV40-transformed African green monkey kidney cells
(COS-1) and Chinese hamster ovarian (CHO)-KI cells were
grown in Dulbeccos modified Eagles medium (Sigma), 4 mM
L-glutamine, 100 IU/ml penicillin, 100 g/ml streptomycin,
and 10% fetal calf serum (Invitrogen; Complete medium). Cells
were seeded at 2 106 cells/60-mm dish and grown overnight
until 95% confluence. Transient transfection of the cells was
performed using LipofectamineTM 2000 (Invitrogen), accord-
ing to the manufacturer’s recommendations. In some experi-
ments, after 40 h of transfection, the cells were treated for 8 h
with the proteasomal inhibitor MG132 (25 M, Calbiochem).
Co-transfection with pEGFP-C1 revealed a transfection effi-
ciency of about 45%. For selection of stable transfected clones
expressing pcDNA3/6myc or pcDNA3/6myc-HAS2, 24 h after
transfection, CHO-KI cells were passaged in medium contain-
ing 600 g of G418/ml, at 1:10 series dilutions.
Determination of SynthesizedHyaluronan andHAS2 Expres-
sion by the Transfectants—Hyaluronan synthesized de novo by
untransfected COS-1 cells or COS-1 cells transiently trans-
fected with pcDNA3 vector alone (mock) as well as with tagged
HAS2 or HAS3 constructs, was determined after different time
periods by using a microtiter-based assay, as described previ-
ously (28). Similarly, the hyaluronan-synthesizing capacity of
CHO-KI cells stably transfected with 6myc-HAS2, was also
determined. This assay is based on the specific binding of hy-
aluronan to the G1 globular domain of aggrecan. Briefly, condi-
tioned media obtained at different time points after the trans-
fections were added to a 96-well microtiter plate (MaxiSorp
Nunc-Immuno plates, Nalge Nunc International) precoated
with G1 protein. As a standard, highly purified hyaluronan
(0–100 ng/ml, Q-Med, Uppsala, Sweden) were used. After 1 h
of incubation at 37 °C, sampleswere incubated for another hour
with biotinylated G1 protein; its binding to hyaluronan was
then determined by incubation for 1 h with peroxidase-conju-
gated streptavidin (1:1600 diluted; RPN 1051, GE Healthcare),
followed by washings and incubation for 15 min with 3,3,5,5-
tetramethyl-benzidine liquid substrate for ELISA (Supersensi-
tive; T4444, Sigma). The reaction was stopped with H2SO4,
and the absorbance was measured at 450 nm using an ELISA
reader. The intervariation of this assay is less than 10%.
Cell monolayers were washed with cold phosphate-buffered
saline and scraped into sucrose buffer: 10mMHepes, pH7.1, 0.5
mM dithiothreitol (DTT), and 0.25 M sucrose, supplemented
with protein inhibitors (10 g/ml leupeptin, 3 g/ml pepstatin
A, 5g/ml aprotinin, 0.5g/ml pefabloc, 1mMNa3VO4, 50mM
NaF, 1 mM DTT). Then samples were sonicated and subjected
to centrifugation in a BeckmanUltra-Centrifuge TL-100 with a
TLS-55 rotor at 43,000 rpm (150,000  g) for 60 min at 4 °C,
using Ultra-Clear centrifuge tubes (11  34 mm, Beckman).
The high speed pellets (membrane fractions) were resuspended
in 600 l of TBS/Ca2 buffer (25 mM Tris, 150 mMNaCl, 1 mM
CaCl2, pH 7.8), supplemented with 0.1% SDS and 0.5%Nonidet
P-40 as well as the protease inhibitors described above, and
incubated for 1 h at 4 °C. In some of the experiments, the TBS/
Ca2 buffer was in addition to protease inhibitors supple-
mented with 1% SDS or 1% digitonin. After centrifugation at
14,000 rpm for 10 min at 4 °C, the protein concentration in the
supernatant was measured using the BCA Protein Assay Re-
agent kit (Pierce). Then, samples were divided to be processed
for immunoprecipitation (250 g of protein each) and immu-
noblotting (30 g of protein each).
For immunoblotting, aliquots from membrane fractions
were subjected to SDS-PAGE in 10% polyacrylamide gels and
the proteins were transferred to nitrocellulose membranes
(Hybond-C extra). All samples were reduced with DTT and
alkylated with iodoacetamide. Nonspecific binding sites on
membranes were blocked for 3 h at room temperature with 3%
nonfat dried milk in TBS-T (Tris-buffered saline containing
0.1% Tween 20), followed by overnight incubation with anti-
Flag, anti-Myc, or anti-HAmonoclonal antibody at dilutions of
1:1000, 1:800, or 1:200 in1% bovine serum albumin/TBS-T,
respectively. HASs were also detected with anti-HAS2 IgG (5
g/ml; Ref. 28) and anti-HAS3 IgG (1 g/ml). For ubiquitina-
tion studies, the anti-ubiquitin P4D1 antibodies were used at a
dilution of 1:200. After four washes, membranes were incu-
bated for 1 h with horseradish-peroxidase-conjugated goat
anti-mouse IgG at a 1:10,000 dilution in blocking solution. The
immunocomplexes were visualized using enhanced chemilu-
minescence according to the manufacturer’s instructions. For
re-blotting, themembranes were stripped with stripping buffer
(0.2 M NaOH, 0.5 M NaCl) for 10 min and reblotted with anti-
bodies, as specified above. Silver staining was performed, as
described before (32).
For co-immunoprecipitation, sample aliquots from mem-
brane fractions solubilized in TBS/Ca2 buffer containing 0.1%
SDS and 0.5%Nonidet P-40 or 1% digitonin were precleared by
protein G-Sepharose (50% slurry in TBS/Ca2 buffer; GE
Healthcare) before 2 g of anti-Flag, 1 g of anti-Myc, or 1 g
of anti-HA monoclonal antibodies were added followed by 2 h
incubation at 4 °C. Samples solubilized with TBS/Ca2 buffer
containing 1% SDS, were diluted 2-fold before pre-clearing.
Then, 30 l of protein G-Sepharose was added, and the mix-
tures were incubated for an additional 1 h, at 4 °C, followed by
washing (3500 rpm for 3 min). After resuspension in loading
buffer, samples were subjected to immunoblotting.
Analysis of Proteins by MALDI-TOF Mass Spectrometry—
Bands observed atmolecularmasses of 53–58 kDa (for the Flag-
HAS2 transfectants), 65–74 kDa (for the 6myc-HAS2 transfec-
tants) and molecular mass species of about 120 kDa were
excised from silver-stained gels and treated for in-gel digestion,
as described (33). In brief, the bands were destained and dried,
then trypsin (sequence grade porcine, modified, Promega) was
added, and the samples were digested overnight at 30 °C. The
peptidemixtures were concentrated and desalted on aZipTip
C18 (Millipore) and applied directly to the sample target. The
peptide mass fingerprints were obtained on an Ultraflex TOF/
TOF MALDI mass spectrometer (Bruker Daltonics) using
-cyano-4-hydroxy-cinnamic acid as matrix. The identities of
the protein bands were obtained by scanning the sequence data
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base NCBInr using the search engine ProFound with the pep-
tide mass lists.
The potential presence of Ub in samples of slower migrating
species with about 5–9 kDa higher molecular mass was ana-
lyzed using GPMAW (Lighthouse Data, Odense, Denmark) by
allowing the addition of tryptic peptides from the C-terminal
part of Ub to a lysine residue, i.e. GG (114.05 Da) or LRGG
(383.24 Da), to the mass of the predicted tryptic peptides of
HAS2.
Site-directed Mutagenesis—Point mutants of Lys-190 in
pcDNA3-Flag-HAS2 and pcDNA3–6myc-HAS2 were gen-
erated by site-directed mutagenesis. The following muta-
genic primer and its complementary were designed to
change Lys to Arg (R) at position 190 (K190R; primer is
shown in the sense orientation with the altered codon in
boldface, 5-ATGCAAAAATGGGGTGGAAGGAGAG-
AAGTCATGTACACAGCC-3).
The site-directed mutagenesis was performed using two
QuikChange (Stratagene), according to the manufacturer’s
instructions. The pcDNA3 plasmid containing either the Flag-
HAS2 or the 6myc-HAS2 transcriptswere used as a template for
the primer extension reactions with the pair of mutagenic
primers.Mutant strand synthesis reactionwas performed using
the polymerase chain reaction (PCR) and pfuDNApolymerase.
PCR was performed for 18 cycles: 95 °C for 15 s, 55 °C for 15 s,
and 78 °C for 3 min. The amplification products were treated
with DpnI to digest the parental methylated and hemimethyl-
ated DNA at 37 °C for 1 h. The digested reaction was trans-
formed into DH5 competent cells,
purified using the Nucleospin Plas-
mid (Macherey-Nagel), and colonies
were screened for the desiredmuta-
tions by sequencing isolated DNA
using ABI Prism 310 genetic Ana-
lyzer (Applied Biosystems).
RESULTS
HAS2 and HAS3 Proteins Form
Homo- and Hetero-oligomers—The
expression and activity of Flag-
HAS2 and 6myc-HAS2 proteins
were studied in transiently trans-
fected COS-1 cells. Both constructs
gave rise to active HAS molecules,
as revealed by increased hyaluronan
synthesis (Fig. 1A and subsequent
figures).
Total cell lysate as well as anti-
Flag- or anti-Myc-immunoprecipi-
tated material were subjected to
SDS-PAGE followed by immuno-
blot analysis (Fig. 1, A and B). Ini-
tially, as a way to ensure efficient
solubilization of Flag- and 6myc-
HAS2 proteins from COS-1 mem-
brane fraction, the ionic detergent
SDS at a concentration of 1% was
used. In addition to the 65-kDa
6myc-HAS2 species, bands of 74 kDa and about 130–170 kDa
(Fig. 1A) were detected. Notably, the 74-kDa component
(marked with an open arrowhead) was readily detected 24–48
h after transfection, coincident with increase in the amount of
synthesized hyaluronan by 6myc-HAS2 transfectants. Simi-
larly, in addition to the Flag-HAS2 band of a molecular mass of
about 53 kDa other immunoreactive bands of 58 kDa and about
110 kDa were seen using anti-CGR antibodies against the Flag-
HAS2 (Fig. 1B and Ref. 28). Similar results were obtained by
extraction with TBS/Ca2 buffer supplemented with 1% digi-
tonin (supplemental Fig. S1) or supplemented with 0.1% SDS
and 0.5% Nonidet P-40, which was used for all subsequent
experiments (Fig. 1B). No differences in the pattern of immu-
noreactive bands were observed when the SDS-PAGE was per-
formed under non-reducing compared with reducing condi-
tions (data not shown).
To identify the silver-stained proteins (Fig. 1B), analysis by
mass spectrometry and peptide mass fingerprinting was per-
formed. This analysis identified the 53-kDa band to be the
mouse HAS2 isoform (Table 1, sequence coverage was 32%). In
addition, material excised from the 110-kDa species of silver-
stained gels indicated the presence of HAS2 (the sequence cov-
erage was 18%), suggesting that HAS2 may form dimers (data
not shown).
To verify that HAS2 forms homodimers, a co-immunopre-
cipitation experiment was performed. Immunoprecipitation by
Flag antibodies of lysate from COS-1 cells transfected with
Flag-HAS2 and 6myc-HAS2, followed by immunoblotting with
FIGURE 1. Structure and activity of HAS2 expressed in COS-1 cells. A, membrane fractions from COS-1 cells
transiently transfected with 6myc-HAS2 or with empty vector (mock), were solubilized in TBS/Ca2 buffer
supplemented with 1% SDS. Total cell lysates were separated by SDS-PAGE followed by immunoblotting (IB)
with Myc antibodies to detect the expression of 6myc-HAS2. The hyaluronan content in conditionedmedia at
different time points was determined as described under “Materials and Methods.” The error bars indicate
ranges of duplicate samples. B, membrane fractions from COS-1 cells transiently transfected with 6myc-HAS2,
Flag-HAS2, or transfectedwith empty vectors were solubilized in TBS/Ca2 buffer supplementedwith 1% SDS
or 0.1% SDS and 0.5% Nonidet P-40. Total cell lysates or immunoprecipitated (IP) material were separated by
SDS-PAGE, and the gels were subjected to silver-staining or IB, as described under “Materials and Methods.”
Immunoreactive bands were visualized with antibodies against HAS2 (-CGR) and myc. Filled arrowheads
indicate the position of oligomeric- and polymeric-tagged HAS2 species. Open arrowheads indicate a slower
migrating species of tagged HAS2. Data in panels A and B represent one of two and one of three experiments
with similar results, respectively.
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Myc antibodies revealed a band at the expected size (Fig. 2A),
suggesting the formation of dimers or oligomers. To investigate
whether the HAS2 protein in addition to homo-oligomers, can
form hetero-oligomers with another HAS isoform, COS-1 cells
were co-transfected with 6myc-HAS2 and Flag-HAS3. After
immunoprecipitation with Myc anti-serum, immunoblotting
with anti-HAS3 antibodies revealed a band of amolecular mass
of about 55 kDa, i.e. a similar size as that of the HAS3 band seen
in total cell lysates (Fig. 2B). As a control, the filter was then
stripped and blotted with a Myc
antiserum, which revealed the
monomeric 6myc-HAS2 band and
the about 8 kDa higher immunore-
active band (marked with an open
arrowhead). These data demon-
strate that HAS2 and HAS3 iso-
forms interact and form hetero-
meric complexes. The functionality
of the transfected 6myc-HAS2 and
Flag-HAS3, as well as combinations
thereof, was confirmed by the pro-
duction of hyaluronan in the condi-
tioned media (Fig. 2, A and B).
HAS2 Is Both Mono- and Poly-
ubiquitinated—Because monoubiq-
uitination of proteins is character-
ized by about an 8-kDa mobility
shift on SDS-PAGE, we hypothe-
sized that the slower migrating
components of apparent molecular
masses of 5–8 kDa higher than
the monomeric HAS2 isoforms
(denoted with open arrowheads,
Figs. 1 and 2) could reflect mono-
ubiquitination of Flag-HAS2 (58
kDa) and 6myc-HAS2 (74 kDa). As
shown in Fig. 3A, MALDI-TOF
analyses of the 65 and 74 kDa bands
of the silver-stained species indi-
cated that they were both derived
from HAS2 (minimum sequence
coverage of 30%). Furthermore, the peptide mass lists were
scanned for the addition of GG or LRGG (the C-terminal tryp-
tic peptides of ubiquitin) onto lysine residues in HAS2. A pep-
tide of mass 1984.014 Da was found in the 74 kDa form, but not
in the 65 kDa form, suggesting that the peptide 187-
WGGK*REVMYTAFR-199, was ubiquitinated at Lys-190
(K190; indicated by an asterisk); the presence of the bulkyUbon
Lys-190may explainwhy trypsin did not cleave after Lys-190 or
FIGURE 2. 6myc-HAS2 forms homo-oligomers and hetero-oligomers with Flag-HAS3. 6myc-HAS2, Flag-
HAS2, and/or Flag-HAS3 were transiently transfected into COS-1 cells. Lysates were subjected to immunopre-
cipitation with antibodies against Flag- or 6myc-HAS2, samples were resolved by SDS-PAGE and possible
homo-oligomerization (A) as well as hetero-oligomerization (B) were analyzed with immunoblotting with
anti-Myc or anti-Flag antibodies, aswell aswith an antiserumagainst HAS3. Thehyaluronan content in the 48h
conditionedmedia was measured as described under “Materials andMethods.” Data in panels A and B are the
mean of duplicate variation from a representative experiment out of two with similar results.
TABLE 1
Identification of mouse HAS2 by peptide mass fingerprint analysis
The 53 kDa band from silver-stained SDS-PAGEwas subjected to tryptic in-gel digestion and analysis of peptides byMALDI-TOF. An unbiased search (all species, sizes up
to 3000 kDa, one-allowed missed cleavage) resulted in identification of HAS2 from mouse with high probability (9.7  107). This table shows the 17 tryptic peptides
identified making up 32% of the mouse HAS2 sequence.
Measured mass Calculated mass Error (Da) Residues Start To Missed cut Sequence
806.446 806.447 0.001 6 11 0 FLCVLR
926.430 926.428 0.002 421 428 0 SSFASCLR
944.493 944.482 0.010 347 353 0 WLNQQTR
1015.495 1015.479 0.015 192 199 0 EVMYTAFR
1171.600 1171.580 0.019 191 199 1 REVMYTAFR
1228.595 1228.569 0.026 260 268 0 YWMAFNIER
1393.712 1393.690 0.022 336 346 0 CLTETPIEYLR
1458.736 1458.714 0.022 248 259 0 YDSWISFLSSVR
1523.721 1523.701 0.020 361 371 0 EWLYNAMWFHK
1568.815 1568.815 0.000 166 179 0 ESSQHVTQLVLSNK
1996.949 1996.956 0.007 84 100 0 TVALCIAAYQEDPDYLR
2068.035 2068.050 0.015 228 247 0 VLEEDPMVGGVGGDVQILNK
2125.046 2125.050 0.004 84 101 1 TVALCIAAYQEDPDYLRK
2353.017 2353.010 0.007 269 288 0 ACQSYFGCVQCISGPLGMYR
2369.038 2369.005 0.033 269 288 0 ACQSYFGCVQCISGPLGMoxYR
2620.314 2620.271 0.043 156 179 1 GPGETEESHKESSQHVTQLVLSNK
2674.247 2674.180 0.067 204 227 0 SVDYVQVCDSDTMLDPASSVEMVK
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Arg-191 during the digestion of 6myc-HAS2.Monoubiquitina-
tion on Lys-190 could also be determined in another cell type,
i.e.CHOcells stably transfected with 6myc-HAS2, that exhibits
a hyaluronan-synthesizing capacity of about 0.3 g of hyaluro-
nan per 100 g of protein (supplemental Fig. S2).
To investigate further the ubiquitination of HAS2, COS-1
cells were co-transfected with 6myc- or Flag- HAS2 and HA-
tagged ubiquitin (HA-Ub wt) (Fig. 3B). Smeary bands were
detected by immunoblotting with HA antibodies from 6myc-
HAS2 or Flag-HAS2 immunoprecipitates, indicating that
HAS2 is post-translationally modified by polyubiquitin mole-
cules, in addition to monoubiquitination (denoted with open
arrowheads). We then investigated whether the polyubiquitin
chains on the HAS2 protein were linked at Lys-48 and/or
Lys-63 of ubiquitin, by comparing the incorporation intoHAS2
of wt ubiquitin (HA-Ub wt), and K48R (HA-Ub K48R) or K63R
(HA-Ub K63R) point mutants of Ub. Immunoprecipitation of
transfected HAS2 followed by immunoblotting by the antibody
P4D1 which recognizes both poly- and monoubiquitinated
protein and an anti-HA antibody
revealed strong smeary bands after
transfection of wt HA-Ub, as well as
K48R and K63R mutant ubiquitin
(Fig. 4A). Altogether, these results
suggest that HAS2 molecules are
modified with polyubiquitin chains
linked to both Lys-48 and Lys-63
residues.
Because Lys-48-linked polyubiq-
uitination is linked to protein turn-
over by targeting for degradation
in proteasomes, we evaluated the
physiological importance of poly-
ubiquitination for the proteasomal
degradation of HAS2. As shown in
Fig. 4B, ectopic overexpression of
Flag- and 6myc-HAS2 in the pres-
ence of the proteasomal inhibitor
MG132 increased slightly the pool
of polyubiquitinated HAS2, as
determined by the anti-ubiquitin
antibody P4D1.Notably, blocking of
proteasome-mediated degradation
did not significantly affect the ex-
pression levels of Flag- and 6myc-
HAS2 proteins, nor either their hy-
aluronan-synthesizing capacity (Fig.
4B), suggesting that only a minor
pool of HAS2 were polyubiquiti-
nated, possibly reflecting not prop-
erly folded molecules.
Monoubiquitination of HAS2 Is
Important for Its Hyaluronan-syn-
thesizing Capacity—To verify that
HAS2 is monoubiquitinated on
Lys-190, we created tagged HAS2
K190R point mutants. COS-1 cells
were co-transfected with HA-Ub
along with Flag- and 6myc-HAS2, as well as Flag- and 6myc-
HAS2 K190R mutants. The cells were then lysed, followed by
immunoprecipitation by Flag or Myc antibodies; samples were
subjected to SDS-PAGE and immunoblot analysis with anti-
bodies to Myc or Flag. A slower migrating species of tagged wt
HAS2 were seen in the presence of HA-Ub wt (open arrow-
heads, Fig. 5A); however, such bands were less evident upon
ectopic expression of the Flag- or 6myc-HAS2 K190Rmutants.
These findings verified that Lys-190 is a major, although not
the only, ubiquitinated site. The size of the modified HAS2
molecule suggests that Lys-190 is monoubiquitinated, but
we cannot exclude the possibility that it is also poly- and/or
multiubiquitinated.
Monoubiquitination has been demonstrated to regulate
localization and activity of certain proteins by proteasome-in-
dependent cellular processes (34, 35). To explore the physiolog-
ical role of Lys-190 monoubiquitination of the HAS2 protein
and its possible importance for HAS2 activity, we investigated
the hyaluronan-synthesizing capacity of HAS2 K190R mutants
FIGURE 3.Mono- and polyubiquitination of HAS2 expressed by COS-1 cells. COS-1 cells were transfected
with 6myc-HAS2, Flag-HAS2, or a mock construct in the absence or presence of HA-Ub. A, lysates were sub-
jected to immunoprecipitation by Myc antibody followed by SDS-PAGE and immunoblot analysis with anti-
bodies against Myc or silver staining. The immunoreactive bands of 65 and 74 kDa were cut out from the
silver-stained gel and analyzed with MALDI-TOF. B, immunoprecipitation was also performed with antibodies
againstmyc-HAS2 (myc) or Flag-HAS2 (Flag), followed by immunoblot analysis withMyc or Flag aswell as with
antibodies against HA-Ub (HA). Data in A and B are representative experiments out of two and three experi-
ments with similar results, respectively.
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in comparison to wt HAS2. Whereas overexpression of 6myc-
HAS2 or Flag-HAS2 induced higher levels of hyaluronan pro-
duction compared with mock transfectants, overexpression of
the corresponding K190R HAS2 mutants did not induce any
hyaluronan production (Fig. 5B), suggesting that monoubiq-
uitination of HAS2 at Lys-190 is important for the enzymatic
activity of HAS2.
We then examined the role of Lys-190 monoubiquitination
for the formation of oligomeric HAS2 structures. Immunopre-
cipitation with antibodies against Flag, followed by immuno-
blotting with anti-Myc antibodies, revealed heterodimers or
oligomers between wt HAS2 and HAS2 K190R mutant mole-
cules (Fig. 6A; thin arrows), as well as homomeric complexes of
wt or K190R mutant HAS2 molecules (Fig. 6A). Thus, mono-
ubiquitination is not necessary for dimerization of HAS2.
Importantly, analysis of the hyaluronan content in the con-
ditioned media of COS-1 cells co-transfected with equal
amounts of HAS2 wt and K190R mutant constructs, revealed
slightly lower levels of hyaluronan compared with conditioned
medium of COS-1 cells transfected with wt HAS2 (Fig. 6B). To
evaluate further the functional significance ofmonoubiquitina-
tion ofHAS2 at the Lys-190 residue, COS-1 cells were co-trans-
fected with wt HAS2 and increasing concentrations of the
HAS2 K190R mutant (Fig. 7). COS-1 cells transfected with wt
Flag or HA-tagged HAS2 synthesized hyaluronan whereas
Flag-HAS2K190R mutants did not
exhibit any detectable hyaluronan-
synthesizing capacity. Expression of
increasing amounts of the K190R
mutant HAS2 molecule gradually
decreased the synthesis of hyaluro-
nan (Fig. 7). Because wt and K190R
mutant HAS2 form dimers, these
results suggest that the functional
form of HAS2 is a dimer and that
monoubiquitination of Lys-190 is
crucial for the activity of HAS2 in
the dimer. In addition, overexpres-
sion of wt HA-Ub did not signifi-
cantly decrease the HAS2-induced
hyaluronan production, suggesting
that HAS2 ubiquitination at other
sites than Lys-190 does not regulate
HAS2 hyaluronan synthesizing ac-
tivity and does not interferewith the
structural organization of the oligo-
meric forms.
DISCUSSION
We show in the present report
that HAS2 forms dimers or olig-
omers, and that HAS2 activity is
regulated by ubiquitination. HAS2
dimerization or oligomerization
was demonstrated by co-immuno-
precipitation of differentially tagged
HAS2 molecules. Interestingly,
HAS2 oligomers could be detected
in SDS-PAGE gels after extraction in TBS/Ca2 buffer, supple-
mented with 0.1% SDS and 0.4%Nonidet P-40, or with themild
non-anionic detergent digitonin (supplemental Fig. S1), but
also after extraction in TBS/Ca2 buffer supplemented with 1%
SDS (Fig. 1). Evidence for SDS-resistant HAS2 dimers in CHO
cells stably transfected by HAS2 was also obtained (data not
shown). Thus, the dimers are kept together by strong interac-
tions. In a recent study it was demonstrated that HAS1 forms
multimers through intermolecular disulfide bonds (36). How-
ever, the HAS2 dimers we observed were seen both in the pres-
ence and absence of reducing agents, making it unlikely that
disulfide bonds are involved. The nature of the bonds that keep
the SDS-resistant HAS2 dimers together remains to be eluci-
dated. The observation of a dimeric structure of HAS2 is con-
sistent with our earlier findings that the HAS activity may
reside in a large protein complex (37).
An indication that HAS2 dimerization may be of functional
importance came from the other finding of our study, i.e. our
demonstration that HAS2 is ubiquitinated. We identified one
acceptor site for ubiquitination, i.e. Lys-190 (Table 1), in tran-
siently transfected COS cells (Fig. 3A) and in stably transfected
CHO cells (supplemental Fig. S2). Interestingly, mutation of
this residue led to inactivation of the enzymatic activity of
HAS2. Moreover, the K190R mutant HAS2 was shown to
dimerizewithwtHAS2, and suppressed the activity of wtHAS2
FIGURE4.EffectsofMG132onpolyubiquitinationandactivityof taggedHAS2.A, Flag-pcDNA3vector and
Flag-HAS2aloneor togetherwithHA-Ub (eitherwtor theK48RandK63RUbmutants)were expressed inCOS-1
cells at different amounts. Cell extracts were subjected to immunoprecipitation with antibodies against Flag-
HAS2 (Flag) and sequential immunoblot analysis with antibodies against HA-Ub (P4D1), Flag-HAS2 (Flag), and
anti-HA. B, mock-transfected and Flag- or 6myc-HAS2 transfected cells were treated with the proteasomal
inhibitor MG132 (25 M) for 8 h. Cell lysates were subjected to immunoprecipitation with antibodies against
Flag-HAS2 (Flag) and 6myc-HAS2 (myc), followed by immunoblot analysis with antibodies against tagged
HAS2, then the membranes were stripped and reprobed with anti-HA-Ub (P4D1). Conditioned media, after
48 h of incubation, were analyzed for hyaluronan content as described under “Materials and Methods.” Each
value depicts mean of triplicates S.D. Data in A and B represent one of three experiments performed with
similar results.
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in such dimers. Our data suggest that monoubiquitination of
Lys-190 of both HAS2 subunits are necessary for activity.
Another conclusion from the observation that K190R
mutant HAS2 can inhibit the activity of HAS2 is that a dimeric,
or possibly oligomeric, structure of HAS2 is necessary for its
function. The reason for the need for dimerization or oligomer-
ization of HAS2 for its activity remains to be elucidated. It
should be noted, however, that hyaluronan is secreted through
the plasma membrane in conjunction with its synthesis and
that HAS isoforms are rather small transmembrane proteins;
possibly more than one HASmolecule is needed to form a pore
through which hyaluronan is extruded. Notably, there are indi-
cations that phospholipids, such as cardiolipin, are required for
Streptococcus pyogenes HAS activity (38, 39). It is possible that
the activity ofmammalianHAS can also be affected by the lipids
in the plasma membrane. Furthermore, it has been reported
that an ABC transporter system is involved in the transport of
hyaluronan to the extracellular space (40, 41). Thus, it is possi-
ble that the activities of mammalian enzymes and the amounts
of hyaluronan synthesized, are affected by the oligomeric state
of HAS molecules, monoubiquitination, ABC transport sys-
tems, and phospholipid microenvironment.
Another interesting question for future studies is to elucidate
the exact role of ubiquitination forHAS2 function. It is possible
that ubiquitination of Lys-190 is needed for the docking of the
substrates required for hyaluronan synthesis, or for the actual
catalysis. Noteworthy, Lys190 is located in the HAS2 glycosyl-
transferase-2 conserved domain. Significantly, amino acid
sequence alignment between vertebrate HASs within the gly-
cosyltransferase region, shows that Lys-190 is conserved
among all otherHAS isoforms, suggesting that itmay have a key
role for the function of HAS (42). Interestingly, some ubiquiti-
nation remained in theK190Rmutant, suggesting that there are
also other sites of ubiquitination inHAS2, the function ofwhich
remains to be determined.
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Supplemental Figures 
 
FIG. S1. Solubilization of 6myc-HAS2 and Flag-HAS2 by digitonin 
Membrane fractions from COS-1 cells transiently transfected with Flag-HAS2, 6myc-HAS2 or with 
the corresponding empty vector (mock), were solubilized with a TBS/Ca2+ buffer, supplemented with 
1% digitonin and protease inhibitors, as described in Materials and Methods. Lysates were 
immunoprecipitated with anti-Flag antibodies, then resolved by SDS-PAGE and analysed by 
immunoblotting with anti-Flag, anti-myc or CGR antibodies to detect HAS2. The data shown is a 
representative experiment out of four performed. 
 
FIG. S2. HAS2 is mono-ubiquitinated in CHO-KI cells stably transfected with 6myc-HAS2  
Membrane fractions from CHO-KI cells stably transfected with 6myc-HAS2 or with empty vector 
(mock) were solubilized and cell lysates were immunoprecipitated with anti-myc antibodies, resolved 
by SDS-PAGE and subjected to silver staining. Bands with a molecular mass of 65 kDa and 74 kDa 
from tagged HAS2 stably transfectants were analyzed by MALDI-TOF. Analysis of the 65 kDa band 
indicated the presence of the 6myc-HAS2 isoform (sequence coverage 14%) and that of the 74 kDa 
the presence of 6myc-HAS2-Ub1 (sequence coverage 24%). A peptide with a mass of 1577.732 Da 
was detected in the 74 kDa band  but not in the 65 kDa band, and is suggested to correspond to the 
peptide 180-SICIMQKWGGKR-191 with an addition of 114.04 Da resulting from the C-terminal GG 
of ubiquitin, bound to residue K190. Notably, a peptide of 1307.67 was detected in the 65 kDa band, 
but not in the 74 kDa band; this peptide is produced after tryptic cleavage at K190, that does not occur 
if this residue is modified by ubiquitination, suggesting that the ubiquitin modification at K190 occurs 
at high stoichiometry.. 
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